Ocular Therapeutix, Inc.

NasdaqGM:OCUL 株式レポート

時価総額:US$968.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Ocular Therapeutix マネジメント

マネジメント 基準チェック /14

Ocular Therapeutix'sの CEO はPravin Dugelで、 Apr2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.032%を直接所有しており、その価値は$ 272.95K 。経営陣と取締役会の平均在任期間はそれぞれ0.3年と5年です。

主要情報

Pravin Dugel

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.03%
経営陣の平均在職期間less than a year
取締役会の平均在任期間5yrs

経営陣の近況

Recent updates

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Could Be 45% Below Their Intrinsic Value Estimate

Jun 05
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Could Be 45% Below Their Intrinsic Value Estimate

Ocular Therapeutix: Unveiling Pipeline Progress (AXPAXLI, PAXTRAVA) And Q1 Results

Jun 01

Ocular Therapeutics' Impressive Surge: A Strategic Insight

Mar 19

Ocular Therapeutix: Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement

Feb 11

Ocular Therapeutix Vies With Gene Therapies, Not Just Eylea, For Wet AMD

Jan 10

Optimistic Investors Push Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Up 31% But Growth Is Lacking

Jan 09
Optimistic Investors Push Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Up 31% But Growth Is Lacking

Is Ocular Therapeutix (NASDAQ:OCUL) Using Too Much Debt?

Oct 15
Is Ocular Therapeutix (NASDAQ:OCUL) Using Too Much Debt?

Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load?

Jun 30
Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load?

Analysts Just Slashed Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) EPS Numbers

Mar 08
Analysts Just Slashed Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) EPS Numbers

Is Ocular Therapeutix (NASDAQ:OCUL) Using Debt In A Risky Way?

Feb 11
Is Ocular Therapeutix (NASDAQ:OCUL) Using Debt In A Risky Way?

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Analysts Are More Bearish Than They Used To Be

Nov 16
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Analysts Are More Bearish Than They Used To Be

Despite Lacking Profits Ocular Therapeutix (NASDAQ:OCUL) Seems To Be On Top Of Its Debt

Sep 09
Despite Lacking Profits Ocular Therapeutix (NASDAQ:OCUL) Seems To Be On Top Of Its Debt

Ocular Therapeutix: Trading Ahead Of An Underappreciated Catalyst Event

Aug 15

Some Analysts Just Cut Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) Estimates

May 13
Some Analysts Just Cut Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) Estimates

CEO(最高経営責任者

Pravin Dugel (60 yo)

less than a year

在職期間

Dr. Pravin U. Dugel, M. D. has been Executive Chairman of Ocular Therapeutix, Inc. since February 2024 and also serves as its Chief Executive Officer and President since April 15, 2024. He served as Presid...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Donald Notman
Chief Financial Officer6.8yrsUS$1.34m0.050%
$ 488.5k
Jeffrey Heier
Chief Scientific Officerless than a yearUS$329.90k0.031%
$ 299.6k
Pravin Dugel
Executive Chairmanless than a yearデータなし0.032%
$ 310.2k
Karen-Leigh Edwards
Chief Operations Officerless than a yearデータなしデータなし
Peter Jarrett
Chief Technology Officerno dataデータなしデータなし
William Slattery
Vice President of Investor Relationsno dataデータなしデータなし
Philip Strassburger
General Counsel3.8yrsUS$2.41mデータなし
William Ransone
Vice President of Global Sales & Marketingno dataデータなしデータなし
Tracy Smith
Vice President of Human Resources3.8yrsデータなしデータなし
Steve Meyers
Chief Commercial Officer1.4yrsデータなしデータなし
Peter Kaiser
Chief Development Officerless than a yearデータなしデータなし
Sanjay Nayak
Chief Strategy Officerless than a yearデータなし0.11%
$ 1.1m

0.3yrs

平均在職期間

63yo

平均年齢

経験豊富な経営陣: OCULの経営陣は 経験豊富 とはみなされません ( 0.3年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Pravin Dugel
Executive Chairmanless than a yearデータなし0.032%
$ 310.2k
Charles Warden
Lead Independent Director16.4yrsUS$303.61k0.031%
$ 302.9k
Merilee Raines
Independent Director2.8yrsUS$263.61k0.0058%
$ 55.9k
Richard Lindstrom
Independent Director11.6yrsUS$261.11k0.090%
$ 866.9k
Adrienne Graves
Independent Directorless than a yearUS$397.89kデータなし
Leslie Williams
Independent Director5.3yrsUS$261.11k0.0087%
$ 83.9k
Seung Hong
Independent Director5yrsUS$248.61k0.0058%
$ 55.9k

5.0yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: OCULの 取締役会経験豊富 であると考えられます ( 5年の平均在任期間)。